Clinical Trial

A Study of GSK4771261 in Healthy Participants Aged 25 to 55 Years of Age Inclusive

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a first time in Asia (FTIA) study of GSK4771261 in healthy participants of Chinese, Japanese, and White/European ancestry. The study will test whether GSK4771261 is safe, well-tolerated, how it is processed in the body, and whether it triggers an immune response.
Trial Details
NCT Number NCT07600450
Lead Sponsor GlaxoSmithKline
Conditions Kidney Disease
Enrollment 30 participants
Start Date 2026-05-15
Primary Completion 2026-09-22 (estimated)
Study Completion 2026-09-22 (estimated)
Updated on ClinicalTrials.gov 2026-05-20